Kigen develops synthetic biology manufacturing platforms for chronic neuroimmune disease treatments, combining AI-driven protein engineering with precision fermentation to produce therapeutic molecules that were previously inaccessible at scale. The company replaces toxic multi-step chemical synthesis with clean single-enzyme processes, targeting upstream molecular pathways rather than downstream events. This approach enables production at costs and purities that make global therapeutic access possible for conditions affecting hundreds of millions worldwide.
Funding
Funding not disclosed
Founders
Product
Problem
Chronic neuroinflammatory diseases affect hundreds of millions of people worldwide, yet current treatments focus on downstream events rather than addressing root causes. Targeting upstream molecular pathways at therapeutic scale has been impossible with existing manufacturing approaches, limiting patient access to potentially more effective treatments.
Solution
Kigen builds synthetic biology infrastructure to manufacture effective neuroinflammatory treatments by combining AI-driven protein engineering with scalable synthetic biology manufacturing processes. The platform replaces complex chemical synthesis with single-enzyme precision, enabling production of therapeutic molecules that were previously inaccessible at meaningful scale. By leveraging natural enzymes augmented with computational protein engineering, Kigen produces precision fermentation manufacturing that replaces toxic multi-step chemical synthesis with clean, single-enzyme processes. This approach enables production at costs and purities that make global therapeutic access possible for chronic neuroimmune conditions.
Target Audience
Primary customers are pharmaceutical and biotechnology companies developing chronic neuroimmune disease treatments, as well as healthcare systems and research institutions seeking scalable access to upstream-targeting therapeutics.
Features
- AI-driven protein engineering that augments natural enzymes for enhanced therapeutic production
- Single-enzyme precision manufacturing that replaces toxic multi-step chemical synthesis
- Scalable synthetic biology manufacturing processes for previously inaccessible therapeutic molecules
- Precision fermentation platform targeting upstream molecular pathways in neuroinflammatory disease
- Computational engineering pipeline that combines natural biology with synthetic manufacturing methods